2020 Hematology and Oncology Update

This half-day symposium will serve as an update on a range topics, including  benign hematology and malignant hematology; a COVID-19 cancer consortium; survivorship needs for patients; targeted therapies, including proton therapy; and understanding the team approach to cancer care for better outcomes.